VEEV240816C290000
- 3.30
- 0.000.00%
Veeva Systems Newsroom
La Divulgación Científica Dirigida Antes Del Lanzamiento Acelera Un 40% La Adopción Del Tratamiento
Veeva Vault Quality Ayuda a Neuraxpharm a Impulsar Operaciones De Calidad Fluidas
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
Veeva Vault Quality Helps Neuraxpharm Drive Seamless Quality Operations and Collaboration With Over 100 CDMOs
Veeva Systems (VEEV) Stock Moves -1.32%: What You Should Know
Veeva Systems' (VEEV) Vault EDC to Boost Vita Global's Workflow
With 82% Ownership of the Shares, Veeva Systems Inc. (NYSE:VEEV) Is Heavily Dominated by Institutional Owners
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Is Veeva Systems (VEEV) a Good Investment Choice?
Guggenheim Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $233
Express News | Veeva Systems Inc : Guggenheim Raises Target Price to $233 From $211
Buy Rating Affirmed: Strategic CFO Appointment and Solid Financial Outlook at Veeva Systems
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $173
Barclays Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $220
Truist Financial Maintains Veeva Systems(VEEV.US) With Hold Rating
A Quick Look at Today's Ratings for Veeva Systems(VEEV.US), With a Forecast Between $204 to $230
Veeva Systems (VEEV) Receives a Hold From Truist Financial
Balancing Organizational Continuity and Executive Transition Risks: A Hold Rating for Veeva Systems
Veeva Systems Price Target Maintained With a $260.00/Share by Needham